Tower Research Capital LLC (TRC) - INDAPTUS THERAPEUTICS INC ownership

INDAPTUS THERAPEUTICS INC's ticker is and the CUSIP is 45339J105. A total of 20 filers reported holding INDAPTUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INDAPTUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$8,696
-4.5%
4,102
+0.9%
0.00%
Q1 2024$9,108
+10.2%
4,066
-13.4%
0.00%
Q4 2023$8,265
-1.1%
4,696
+54.8%
0.00%
Q3 2023$8,356
-22.8%
3,033
-46.5%
0.00%
Q2 2023$10,820
+98263.6%
5,665
-7.7%
0.00%
Q1 2023$11
+10.0%
6,140
-8.9%
0.00%
Q4 2022$10
-99.0%
6,742
+1980.9%
0.00%
Q3 2022$1,000
-75.0%
324
-81.0%
0.00%
Q2 2022$4,0001,7050.00%
Other shareholders
INDAPTUS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
STRATEGY ASSET MANAGERS LLC 45,336$86,5920.02%
Vivaldi Capital Management LP 24,000$50,8800.01%
INVESTMENT HOUSE LLC 102,437$217,1660.01%
Pine Valley Investments Ltd Liability Co 44,085$93,4610.01%
WELLS FARGO & COMPANY/MN 64$1360.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 692$1,4670.00%
GEODE CAPITAL MANAGEMENT, LLC 59,309$125,7550.00%
Bangor Savings Bank 400$8480.00%
Citadel Advisors 22,210$47,0850.00%
View complete list of INDAPTUS THERAPEUTICS INC shareholders